SpinTEchPortfolio

Physics-based STAGE™ quantitative output and ground truth data used with Canon AiCE (Advanced intelligent Clear-IQ Engine) deep learning reconstruction could significantly expand MRI access for neuroimaging BINGHAM FARMS, MI, and TUSTIN, CA, Jan. 16, 2024 – SpinTech MRI, creators of the STAGE™ (STrategically Acquired Gradient Echo) quantitative magnetic resonance imaging (MRI) software platform, and Canon Medical Systems […]

Collaboration will assess operational and clinical impacts of STAGE through an analysis of neuroimaging efficiency, reporting workflows and clinical outcomes in actual cases. BINGHAM FARMS, MI, Nov. 27, 2023 – SpinTech MRI, creators of the STAGE™ (Strategically Acquired Gradient Echo) quantitative magnetic resonance imaging (MRI) software platform, today announced that Yale New Haven Hospital and

Grand Rapids, MI, July 25th, 2022 — Genesis Innovation Group’s cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Bingham Farms, MI based SpinTech MRI announced a $6.5 million Series A financing.

HOLLAND, Mich., August 9th, 2021—Genesis Innovation Group’s cultivate(MD) Capital Fund II LP, a fund focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, SpinTech, has received FDA 510(k) clearance for their STAGE™ magnetic resonance imaging software. SpinTech is a privately-held medical device company at the frontier

HOLLAND, Mich., December 3rd, 2018— cultivate(MD) Seed Fund, a fund focused on investments in early-stage healthcare companies with innovative technologies, announces its investment into SpinTech.